Stay updated with breaking news from Christopher Stevo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer, Inc. (NYSE:NYSE:PFE) Q1 2022 Earnings Conference Call May 03, 2022, 10:00 ET Company Participants Christopher Stevo - SVP & Chief IR Officer Albert Bourla - Chairman & CEO...
Pfizer Inc. announced today that the European Commission has approved XELJANZ ® for the treatment of active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in patients two years of age and older who have responded inadequately to previous therapy with disease modifying antirheumatic drugs . Two formulations were approved, a tablet and a new oral solution . XELJANZ is the first and only ...